Skip to content

    DMCC Speciality

    DMCC
    Chemicals·8 May 2025
    Management Summary

    DMCC Speciality reported a strong full year FY25 performance with a top line of INR 430 crores and a 13.5% EBITDA margin, despite Q4 margins being impacted by sulfur price volatility. The company is actively diversifying its export markets away from a struggling Europe and has significant growth potential in its Specialty Chemicals segment. However, the imminent commissioning of a new copper smelter poses a risk to the sulfuric acid market.

    Highlights

    5
    • Full year FY25 top line reached INR 430 crores, demonstrating overall growth.

    • EBITDA margins for FY25 stood at a healthy 13.5%.

    • Specialty Chemicals business has significant headroom, with capacity to double current sales of INR 210 crores.

    • Long-term borrowings are now below INR 60 crores, indicating improved financial health.

    • Actively diversifying export markets into Latin America and China to mitigate European slowdown.

    Concerns

    4
    • Q4 FY25 EBITDA margins were compressed due to an 'unusual jump' in sulfur prices.

    • Significant loss of exports to Europe due to increased costs and reduced production in the region.

    • Upcoming commissioning of a large copper smelter in Kutch is expected to put downward pressure on the sulfuric acid market.

    • Boron segment faces continuous supply chain issues as there is no raw material in India.

    What Changed2

    vs Q2 FY26

    Guidance items3 → 5 (+2)Risks discussed5 → 4 (-1)
    Key financials

    Metrics

    5

    Periods

    2

    Q4 FY25

    2
    • Top Line
      ₹125 Cr
    • PAT
      ₹6.47 Cr

    FY25

    3
    • Top Line
      ₹430 Cr
    • PAT
      ₹21.5 Cr
    • EBITDA Margin
      13.5%

    Segment breakdown

    Boron Business
    ₹100 Cr Sales (Past Year)70% Commodity Share30% Higher-Margin Share
    Specialty Chemicals
    ₹51 Cr Revenue (Q4 FY25)₹210 Cr Annual Revenue (Current Capacity)50% Capacity Utilization50% Full Year Mix (vs Bulk)
    List

    Capital allocation

    3
    high confidence
    CategoryHeadline
    Capex

    ₹10 crores

    Debt

    Net ₹60 crores

    Liquidity

    Liquidity disclosed

    Working capital position is quite comfortable.

    Guidance & targets

    5
    CategoryTargetPriority
    Capacity
    Specialty Chemicals Sales Potential
    INR 420 crores
    High
    Product Development
    New Products Commercialization
    New products taken up for commercialization
    Medium
    Growth
    Chemical Industry Growth Rate
    Faster than GDP growth
    Medium
    Profitability
    EBITDA Margin Expansion
    Expansion
    Medium
    Taxation
    Transition to New Tax Regime
    New tax regime (25-26%)
    High

    Specialty Chemicals Margin Recovery

    Next quarter (Q1 FY26)
    CurrentCompressed due to sulfur price in Q4 FY25
    TargetReturn to normal profitability

    Why it matters

    Direct impact on profitability; management expects pass-through of sulfur price increases.

    What happened in the previous quarter is an unusual jump in the sulfur price, which will get reflected in the contract pricing in Q1 of this financial year. So we will be able to pass it on.

    How to verify

    key_financials.metrics[label='EBITDA Margin']

    Risks & concerns

    4
    RiskSeverity

    Copper Smelter Commissioning in Kutch

    Expected to put downward pressure on the sulfuric acid market due to byproduct production.Management acknowledged

    medium

    European Market Conditions

    Increased costs and reduced production in Europe led to lost export sales for DMCC.Management acknowledged

    high

    Sulfur Price Volatility

    Unusual jump in sulfur prices impacted Q4 FY25 margins, though pass-through is expected in Q1 FY26.Management acknowledged

    medium

    Boron Raw Material Supply Chain Issues

    No raw material in India leads to continuous supply chain challenges for the boron segment.Management acknowledged

    medium

    Q&A highlights

    8

    “The correlation is that copper smelters have a byproduct of sulfuric acid, and they can have this without burning sulfur. So when sulfur prices are low, it doesn't matter that much. But when sulfur prices are high, all the sulfur-based sulfuric acid plants are at a disadvantage compared to the smelter-based sulfuric acid plants.”

    Highlights a significant upcoming competitive threat and its mechanism of impact on DMCC's core business.

    asked by Yash Pareek

    2 min read6 chapters

    Detailed Narrative

    01

    Q4 FY25 and Full Year FY25 Financial Performance

    DMCC Speciality Chemicals reported a Q4 FY25 top line of INR 125 crores and a PAT of INR 6.47 crores. For the full financial year 2025, the company achieved a top line of INR 430 crores and a PAT of INR 21.5 crores. The full year EBITDA margin stood at approximately 13.5%. Management highlighted that the previous year's Q4 included an INR 8 crore pre-tax profit from investment sales, which should be considered when comparing year-on-year performance.

    02

    European Market Challenges and Diversification Strategy

    The company faced significant headwinds in European markets, experiencing a loss of export sales due to increased energy costs and reduced production by European chemical companies. In response, DMCC is actively exploring and developing new markets, making headway in Latin American countries and initiating sales into China. While these new markets have not yet fully compensated for the lost European business, management believes they will eventually substitute the demand, anticipating that European industry will eventually take steps to revive itself.

    03

    Impact of Upcoming Copper Smelter on Sulfuric Acid Market

    A key concern raised by management is the imminent commissioning of a large copper smelter in Kutch, expected within the next 3 to 6 months. This smelter will produce sulfuric acid as a byproduct, which is anticipated to create downward pressure on the sulfuric acid market, particularly in Northern Gujarat. This development could put sulfur-based sulfuric acid plants, like DMCC's, at a disadvantage when sulfur prices are high, as smelter-based production does not incur sulfur burning costs.

    04

    Specialty Chemicals Growth Potential and Capacity Utilization

    DMCC's Specialty Chemicals business is currently operating at 50-60% capacity utilization, generating an annual revenue of approximately INR 210 crores. Management stated that the company possesses sufficient reactor capacity to double its current sales in this segment, implying a potential annual revenue of around INR 420 crores. Future growth will focus on increasing utilization and, for mature products, transitioning them to dedicated plants with modest CAPEX of INR 10-15 crores.

    05

    Raw Material Price Volatility and Margin Management

    The company's EBITDA margins in Q4 FY25 were impacted by an 'unusual jump' in sulfur prices. However, DMCC expects to pass on these raw material cost increases through contract pricing adjustments, with the effect anticipated to be reflected in Q1 FY26. The boron segment, which contributed about INR 100 crores in sales in the past year, comprises roughly 70% commodities and 30% higher-margin products, with specialty chemicals generally yielding better margins than bulk chemicals.

    06

    Capital Expenditure and Debt Management

    DMCC is not planning any major capital expenditure at this time, with only a modest plan of INR 10-15 crores for incremental investments or debottlenecking. The company's long-term borrowings have been reduced to below INR 60 crores, and its working capital position is described as comfortable. Annual maintenance CAPEX for sulfuric acid plants typically ranges from INR 1.5-2 crores every one to two years.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.